TrialBritish journal of haematology2021

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.

Patrick Harrington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.